Testimonials

David Nieman, Ph.D.

Director, Human Performance Lab
Appalachian State University, Boone, North Carolina, USA

David Nieman, PhD, Director of the Human Performance Lab at the Appalachian State University in Kannapolis, NC uses the seca mBCA in his human performance research. The body composition analysis provides him with accurate information about a test subject's fat mass, fat-free mass, and skeletal muscle mass.



Obtaining a value of Resting Energy Expenditure can be quite involved. Traditionally, this value is determined with the use of a metabolic chamber or metabolic cart. Research has shown, though, that one can determine RMR using the fat-free mass of a test subject. David Nieman, PhD, Director of the Human Performance Lab at Appalachian State University is using a seca mBCA 514 medical body composition analyser to accurately determine the fat-free mass and thus come to the RMR in seconds, rather than the more time intensive but less accurate methods using a metabolic chamber or cart.

David Voellinger, MD

Bariatric Surgeon
Novant Health, Charlotte, North Carolina, USA

David Voellinger, MD describes the value of body composition analysis in clinical application. He speaks to his use of the seca medical Body Composition Analyzer (mBCA) pre-op and the value of being able to determine the development of fat mass and skeletal muscle mass independently when determining an individualized weight loss regimen for his patients. He appreciates the four-extremities display of muscle mass and the ability to determine whether a patient’s water weight is mostly held in muscle or if it is water otherwise retained in the body.



David Voellinger, MD, describes the shift in focus from a weight loss (BMI) based practice to a body composition based workflow. "The percentage of body fat and the percentage of body muscle is way more important clinically than a number on a scale."

Felice Gersh, MD

Medical Director
Integrative Medical Group of Irvine, California, USA

Felice Gersh, Medical Director at the Integrative Medical Group of Irvine, describes how she uses body composition analysis on Patients that are on the Fasting Mimicking Diet. She has been able to confirm with the seca mBCA 514 that patients lose predominantly fat and not lean muscle mass.



Felice Gersh of the Integrative Medical Group of Irvine, CA declares her goal to prevent changes in body composition of menopausal women by utilizing the seca mBCA 514. This medical device gives her insights into the development of her patient's fat mass, fat-free mass, muscle mass, visceral fat, phase angle and water weight and helps her in determining how to respond with the appropriate hormone therapy.

Gary Donovitz, MD

CEO and Founder of BioTE Medical
BioTE Medical, Irving, Texas, USA

Gary Donovitz, MD, founder and CEO of BioTE Medical (https://www.biotemedical.com/) describes the importance of validated medical body composition analysis with the seca mBCA514 during hormone therapy.

Dr. Suzanne Turner, MD, FAARM, ABAARM

Founder and Medical Director
Vine Medical Associates

In the complex symphony of interactions that are the human body, it is paramount to find an objective "before and after" guide to monitor therapy. We evaluate patients presenting for weight loss, heart disease, chronic infections, hormone replacement therapy, diabetes and more using the seca mBCA. The assessment is simple and quick, the report is easy to understand and explain to patients. The subsequent evaluations are helpful to guide adjustments in care when other tools are less specific, and patients are encouraged by the measured progress beyond the scale or confirmation that their efforts have not been in vain.